SynPhaGen, LLC
Biotech · Private
Platform technology for targeted delivery of therapeutic genes to commensal bacteria in the human body, transforming them into localized therapeutic factories
- Grants
- $290K
- 1 award
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 5
- 2 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20152016
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Construction of bacteriophage nanoparticles for targeted delivery of nucleic acid therapeutics | $289,826 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1490 | Pinto Inc. | — | $20K |
| 1491 | CERACUITY, INC. | — | $3K |
| 1492 | ProtaBody, Inc. | — | $800 |
| 1493 | SynPhaGen, LLC | — | — |
| 1494 | MITOSENSE, INC. | — | $2.2M |
| 1495 | GFREE BIO, LLC | — | — |
| 1496 | BEXION PHARMACEUTICALS, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Treatment delivery system and methodapplication
- Compositions for in vivo Expression of Therapeutic Sequences in the Microbiomeapplication
- Compositions for in vivo Expression of Therapeutic Sequences in the Microbiomegranted
- Therapeutic Phages And Methods For Delivery Of Nucleic Acids For Therapeutic Usesgranted
- Therapeutic Phages And Methods For Delivery Of Nucleic Acids For Therapeutic Usesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.